Toward Greater Human Physiological Relevance
There is growing interest in scalable 3D in vitro technologies and organ-on-a-chip systems that is causing a paradigm shift in how we approach drug discovery and development. But how do you separate the hype from practical innovations that are proven, tested and ready to implement for industry applications? The New Frontiers in 3D conference offers an international forum for you to meet with other leaders and innovators in the field of pharmaceutical drug discovery for discussing challenges and opportunities to advance preclinical research, with an emphasis on translational approaches, challenges, and successes.
This one-day symposium will include sessions on advanced 3D platforms for drug safety and efficacy testing, as well practical guidance for implementing the latest organ-on-a chip microfluidic systems. Keynote and invited speakers from industry and academic institutes will share their experiences and perspectives. Join the discussion and help shape the future of preclinical drug testing.
Who Should Attend
- Pharma and biotech research scientists involved in drug discovery
- Toxicologists engaged in drug safety testing
- Research and innovation management.
- Representatives from regulatory agencies